drugset / Trial / NCT01914913
Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
NaSingle-groupOpen-labelTreatment
Summary
Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is the layer of tissue at the back of the inner eye that converts light images to nerve signals and sends them to the brain.Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs) is used for this condition .
Timeline
- Start
- 2014-09
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | — | — |